ConMed Makes Play For SurgiQuest To Prop Up Surgery Business
This article was originally published in The Gray Sheet
ConMed announced a definitive agreement to acquire the privately held SurgiQuest for $265 million, citing the firm's AirSeal laparoscopic access management technology as a key get for its struggling surgery business.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.